Apyx Medical Corp Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Apyx Medical Corp (APYX) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$3.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-06
- Apyx Medical Corp net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$3.07M.
- Apyx Medical Corp net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$2.14M.
- Apyx Medical Corp net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$1.24M.
- Apyx Medical Corp net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$1.96M.
- Apyx Medical Corp net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$11.11M.
- Apyx Medical Corp net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$23.56M.
- Apyx Medical Corp net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$18.85M.
- Apyx Medical Corp net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$23.28M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.07M 10-Q · filed 2026-08-06 | -$5.21M 10-Q · filed 2026-08-06 | -$6.46M derived: sum of 3 quarters · filed 2026-08-06 | -$8.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$2.14M 10-Q · filed 2026-08-06 | -$3.38M derived: sum of 2 quarters · filed 2026-08-06 | -$5.34M derived: sum of 3 quarters · filed 2026-08-06 | -$9.08M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$3.19M derived: sum of 2 quarters · filed 2026-03-10 | -$6.93M derived: sum of 3 quarters · filed 2026-08-06 | -$11.11M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$1.96M 10-Q · filed 2025-11-06 | -$5.69M derived: sum of 2 quarters · filed 2026-08-06 | -$9.87M 10-Q · filed 2025-11-06 | -$14.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$3.74M 10-Q · filed 2026-08-06 | -$7.91M 10-Q · filed 2026-08-06 | -$12.57M derived: sum of 3 quarters · filed 2026-08-06 | -$17.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$4.17M 10-Q · filed 2026-08-06 | -$8.83M derived: sum of 2 quarters · filed 2026-08-06 | -$13.55M derived: sum of 3 quarters · filed 2026-08-06 | -$20.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | -$4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$9.38M derived: sum of 2 quarters · filed 2026-03-10 | -$15.97M derived: sum of 3 quarters · filed 2026-03-10 | -$23.56M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$4.72M 10-Q · filed 2025-11-06 | -$11.31M derived: sum of 2 quarters · filed 2025-11-06 | -$18.90M 10-Q · filed 2025-11-06 | -$28.52M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$6.59M 10-Q · filed 2025-11-06 | -$14.18M 10-Q · filed 2025-08-07 | -$23.80M derived: sum of 3 quarters · filed 2025-11-06 | -$28.48M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-03-31 | -$7.59M 10-Q · filed 2025-11-06 | -$17.21M derived: sum of 2 quarters · filed 2025-11-06 | -$21.89M derived: sum of 3 quarters · filed 2025-11-06 | -$22.91M derived: sum of 4 quarters · filed 2025-11-06 |
| 2023-12-31 | -$9.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$14.30M derived: sum of 2 quarters · filed 2025-03-13 | -$15.32M derived: sum of 3 quarters · filed 2025-03-13 | -$18.85M 10-K · filed 2025-03-13 |
| 2023-09-30 | -$4.67M 10-Q · filed 2024-11-08 | -$5.69M derived: sum of 2 quarters · filed 2024-11-08 | -$9.23M 10-Q · filed 2024-11-08 | -$15.29M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$1.02M 10-Q · filed 2024-11-08 | -$4.55M 10-Q · filed 2024-08-08 | -$10.62M derived: sum of 3 quarters · filed 2024-11-08 | -$16.41M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-03-31 | -$3.53M 10-Q · filed 2024-11-08 | -$9.60M derived: sum of 2 quarters · filed 2024-11-08 | -$15.39M derived: sum of 3 quarters · filed 2024-11-08 | -$20.84M derived: sum of 4 quarters · filed 2024-11-08 |
| 2022-12-31 | -$6.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$11.86M derived: sum of 2 quarters · filed 2024-03-21 | -$17.31M derived: sum of 3 quarters · filed 2024-03-21 | -$23.28M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$5.79M 10-Q · filed 2023-11-09 | -$11.24M derived: sum of 2 quarters · filed 2023-11-09 | -$17.21M 10-Q · filed 2023-11-09 | -$19.22M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$5.45M 10-Q · filed 2023-08-11 | -$11.42M 10-Q · filed 2023-08-11 | -$13.43M derived: sum of 3 quarters · filed 2023-08-11 | -$17.66M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$5.97M 10-Q · filed 2023-05-11 | -$7.98M derived: sum of 2 quarters · filed 2023-05-11 | -$12.21M derived: sum of 3 quarters · filed 2023-05-11 | -$16.26M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$6.24M derived: sum of 2 quarters · filed 2023-03-16 | -$10.29M derived: sum of 3 quarters · filed 2023-03-16 | -$15.20M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$4.23M 10-Q · filed 2022-11-10 | -$8.29M derived: sum of 2 quarters · filed 2022-11-10 | -$13.19M 10-Q · filed 2022-11-10 | -$14.72M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$4.05M 10-Q · filed 2022-08-11 | -$8.96M 10-Q · filed 2022-08-11 | -$10.49M derived: sum of 3 quarters · filed 2022-08-11 | -$14.22M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$4.91M 10-Q · filed 2022-05-12 | -$6.44M derived: sum of 2 quarters · filed 2022-05-12 | -$10.17M derived: sum of 3 quarters · filed 2022-05-12 | -$14.86M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$5.26M derived: sum of 2 quarters · filed 2022-03-17 | -$9.96M derived: sum of 3 quarters · filed 2022-03-17 | -$11.91M 10-K · filed 2022-03-17 |
| 2020-09-30 | -$3.73M 10-Q · filed 2021-11-12 | -$8.42M derived: sum of 2 quarters · filed 2021-11-12 | -$10.38M 10-Q · filed 2021-11-12 | -$15.81M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$4.69M 10-Q · filed 2021-08-12 | -$6.64M 10-Q · filed 2021-08-12 | -$12.07M derived: sum of 3 quarters · filed 2021-08-12 | -$16.44M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$1.95M 10-Q · filed 2021-05-12 | -$7.38M derived: sum of 2 quarters · filed 2021-05-12 | -$11.75M derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | -$5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$9.80M derived: sum of 2 quarters · filed 2021-03-31 | -$19.71M 10-K · filed 2021-03-31 | |
| 2019-09-30 | -$4.37M 10-Q · filed 2020-11-09 | -$14.27M 10-Q · filed 2020-11-09 | ||
| 2013-12-31 | -$4.34M 10-K/A · filed 2014-05-08 | |||
| 2012-12-31 | $617.00K 10-K/A · filed 2014-05-08 | |||
| 2011-12-31 | $109.00K 10-K/A · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |